Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Danaher NYSE:DHR |
134,18 B | 3,19% | 5/6 | 6,26% | 22,16% | 42,41% | DOWN |
|
Lonza Group SWX:LONN |
35,45 B | 1,21% | 5/6 | 15,12% | 11,77% | 32,73% | DOWN |
|
IQVIA Holdings NYSE:IQV |
28,63 B | 11,60% | 5/6 | 6,13% | 35,15% | 37,21% | DOWN |
|
Labcorp Holdings NYSE:LH |
21,99 B | -2,39% | 2/6 | 6,43% | -18,59% | 19,94% | UP |
|
SGS SWX:SGSN |
16,24 B | 3,61% | 5/6 | 11,25% | 15,17% | 16,53% | DOWN |
|
Eurofins Scientific ENXTPA:ERF |
11,02 B | 4,37% | 4/6 | 3,70% | 14,43% | 16,26% | UP |
|
Dr. Reddy's Laboratories BSE:500124 |
1.044,62 B | 11,32% | 4/6 | -2,80% | -3,47% | 2,82% | UP |
|
Huadong Medicine SZSE:000963 |
61,79 B | 4,38% | 5/6 | 12,11% | 22,75% | 39,58% | DOWN |
|
ICON Public NasdaqGS:ICLR |
8,45 B | 14,78% | 4/6 | -1,47% | 58,41% | 17,48% | DOWN |
|
Charles River Laboratories International NYSE:CRL |
8,49 B | 5,81% | 5/6 | 1,75% | 24,76% | 15,07% | DOWN |
|
Pharmaron Beijing SZSE:300759 |
47,19 B | 20,79% | 5/6 | 31,44% | 72,76% | 39,56% | DOWN |
|
Hangzhou Tigermed Consulting SZSE:300347 |
43,91 B | 10,66% | 4/6 | 21,16% | 56,99% | 29,39% | DOWN |
|
Bachem Holding SWX:BANB |
4,86 B | -5,13% | 3/6 | 56,17% | 19,71% | 23,36% | UP |
|
Asymchem Laboratories (Tianjin) SZSE:002821 |
38,99 B | 13,52% | 3/5 | 23,72% | 41,94% | 18,72% | UP |
|
Siegfried Holding SWX:SFZN |
3,29 B | 12,27% | 5/6 | 3,57% | 22,58% | 38,00% | DOWN |
|
Livzon Pharmaceutical Group SZSE:000513 |
27,25 B | 2,74% | 0/0 | 8,52% | 10,90% | 27,17% | DOWN |
|
Nanjing King-Friend Biochemical Pharmaceutical SHSE:603707 |
15,82 B | 0,00% | 0/0 | 156,26% | -4,09% | 32,79% | DOWN |
|
Zhejiang Jiuzhou Pharmaceutical SHSE:603456 |
15,18 B | 18,08% | 3/5 | 6,21% | 55,43% | 31,82% | DOWN |
|
Porton Pharma Solutions SZSE:300363 |
11,34 B | -24,42% | 3/5 | 85,52% | 1,46% | 42,86% | DOWN |
|
Alivus Life Sciences NSEI:ALIVUS |
119,39 B | 3,62% | 2/4 | 16,18% | -17,38% | 18,74% | UP |
